These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 38180590)

  • 1. Short-term antiplatelet versus anticoagulant therapy after left atrial appendage closure: a systematic review and meta-analysis.
    Zhou Q; Liu X; Gu ZC; Yang X; Huang XH; Wu YZ; Tao YY; Wei M
    J Thromb Thrombolysis; 2024 Feb; 57(2):194-203. PubMed ID: 38180590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and safety of short-term anticoagulant regimens after left atrial appendage occlusion: A systematic review and meta-analysis.
    Zhou Q; Liu X; Yang X; Huang XH; Wu YZ; Tao YY; Wei M
    Thromb Res; 2024 Jan; 233():88-98. PubMed ID: 38035647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN.
    Søndergaard L; Wong YH; Reddy VY; Boersma LVA; Bergmann MW; Doshi S; Kar S; Sievert H; Wehrenberg S; Stein K; Holmes DR
    JACC Cardiovasc Interv; 2019 Jun; 12(11):1055-1063. PubMed ID: 31171282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-Term Antiplatelet Versus Anticoagulant Therapy After Left Atrial Appendage Occlusion: A Systematic Review and Meta-Analysis.
    Osman M; Busu T; Osman K; Khan SU; Daniels M; Holmes DR; Alkhouli M
    JACC Clin Electrophysiol; 2020 May; 6(5):494-506. PubMed ID: 32439033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of different anticoagulation regimens after left atrial appendage occlusion.
    Li W; Gao R; Zhao J; Ren Y; Chen G; Zhu J; Jin K; Zhu L; Ruan Z
    Ann Palliat Med; 2022 Jan; 11(1):201-209. PubMed ID: 35144411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-Term Oral Anticoagulation Versus Antiplatelet Therapy Following Transcatheter Left Atrial Appendage Closure.
    Asmarats L; O'Hara G; Champagne J; Paradis JM; Bernier M; O'Connor K; Beaudoin J; Junquera L; Del Val D; Muntané-Carol G; Côté M; Rodés-Cabau J
    Circ Cardiovasc Interv; 2020 Aug; 13(8):e009039. PubMed ID: 32772571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Latest outcomes of transcatheter left atrial appendage closure devices and direct oral anticoagulant therapy in patients with atrial fibrillation over the past 5 years: a systematic review and meta-analysis.
    Takeda K; Tsuboko Y; Iwasaki K
    Cardiovasc Interv Ther; 2022 Oct; 37(4):725-738. PubMed ID: 35098478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual therapy with oral anticoagulation and single antiplatelet agent versus monotherapy with oral anticoagulation alone in patients with atrial fibrillation and stable ischemic heart disease: a systematic review and meta-analysis.
    Shakir A; Khan A; Agarwal S; Clifton S; Reese J; Munir MB; Nasir UB; Khan SU; Gopinathannair R; DeSimone CV; Deshmukh A; Jackman WM; Stavrakis S; Asad ZUA
    J Interv Card Electrophysiol; 2023 Mar; 66(2):493-506. PubMed ID: 36085242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of left atrial appendage closure versus medical treatment in atrial fibrillation: a network meta-analysis from randomised trials.
    Sahay S; Nombela-Franco L; Rodes-Cabau J; Jimenez-Quevedo P; Salinas P; Biagioni C; Nuñez-Gil I; Gonzalo N; de Agustín JA; Del Trigo M; Perez de Isla L; Fernández-Ortiz A; Escaned J; Macaya C
    Heart; 2017 Jan; 103(2):139-147. PubMed ID: 27587437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term direct oral anticoagulation or dual antiplatelet therapy following left atrial appendage closure in patients with relative contraindications to chronic anticoagulation therapy.
    Faroux L; Cruz-González I; Arzamendi D; Freixa X; Nombela-Franco L; Peral V; Caneiro-Queija B; Mangieri A; Trejo-Velasco B; Asmarats L; Regueiro A; McInerney A; Mas-Lladó C; Estevez-Loureiro R; Laricchia A; O'Hara G; Rodés-Cabau J
    Int J Cardiol; 2021 Jun; 333():77-82. PubMed ID: 33647365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulation Alone vs Anticoagulation Plus Aspirin or DAPT Following Left Atrial Appendage Occlusion.
    Reinhardt SW; Gibson DN; Hsu JC; Kapadia SR; Yeh RW; Price MJ; Piccini JP; Nair DG; Christen T; Allocco DJ; Freeman JV
    J Am Coll Cardiol; 2024 Sep; 84(10):889-900. PubMed ID: 39197978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Network Meta-Analysis of Initial Antithrombotic Regimens After Left Atrial Appendage Occlusion.
    Carvalho PEP; Gewehr DM; Miyawaki IA; Nogueira A; Felix N; Garot P; Darmon A; Mazzone P; Preda A; Nascimento BR; Kubrusly LF; Cardoso R
    J Am Coll Cardiol; 2023 Oct; 82(18):1765-1773. PubMed ID: 37611779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing anticoagulation therapy alone versus anticoagulation plus single antiplatelet drug therapy after transcatheter aortic valve implantation in patients with an indication for anticoagulation: a systematic review and meta-analysis.
    Zhu Y; Meng S; Chen M; Jia R; Nan J; Li H; Zhu H; Li L; Jin Z
    Cardiovasc Drugs Ther; 2021 Oct; 35(5):995-1002. PubMed ID: 33030686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term non-vitamin K antagonist oral anticoagulants vs. warfarin in preventing device-related thrombosis after left atrial appendage closure.
    Chen Y; Zhang Y; Qu L; Huang W; Su X; Chen Y
    J Thromb Thrombolysis; 2021 Oct; 52(3):872-879. PubMed ID: 33666825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation.
    Osmancik P; Herman D; Neuzil P; Hala P; Taborsky M; Kala P; Poloczek M; Stasek J; Haman L; Branny M; Chovancik J; Cervinka P; Holy J; Kovarnik T; Zemanek D; Havranek S; Vancura V; Opatrny J; Peichl P; Tousek P; Lekesova V; Jarkovsky J; Novackova M; Benesova K; Widimsky P; Reddy VY;
    J Am Coll Cardiol; 2020 Jun; 75(25):3122-3135. PubMed ID: 32586585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct Oral Anticoagulant Versus Warfarin After Left Atrial Appendage Closure With WATCHMAN: Updated Systematic Review and Meta-analysis.
    Tan BE; Wong PY; Lee JZ; Tan NY; Rao M; Cheung JW
    Curr Probl Cardiol; 2022 Nov; 47(11):101335. PubMed ID: 35872052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single versus dual antiplatelet therapy following percutaneous left atrial appendage closure-A systematic review and meta-analysis.
    Continisio S; Montonati C; Angelini F; Bocchino PP; Carbonaro C; Giacobbe F; Dusi V; De Filippo O; Ielasi A; Giannino G; Boldi E; Fabris T; D'Ascenzo F; De Ferrari GM; Tarantini G
    Eur J Clin Invest; 2024 Aug; 54(8):e14209. PubMed ID: 38597271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-Analysis of Oral Anticoagulant Monotherapy as an Antithrombotic Strategy in Patients With Stable Coronary Artery Disease and Nonvalvular Atrial Fibrillation.
    Lee SR; Rhee TM; Kang DY; Choi EK; Oh S; Lip GYH
    Am J Cardiol; 2019 Sep; 124(6):879-885. PubMed ID: 31311662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-Dose Direct Oral Anticoagulation vs Dual Antiplatelet Therapy After Left Atrial Appendage Occlusion: The ADALA Randomized Clinical Trial.
    Freixa X; Cruz-González I; Cepas-Guillén P; Millán X; Antúnez-Muiños P; Flores-Umanzor E; Asmarats L; Regueiro A; López-Tejero S; Li CP; Sanchis L; Rodés-Cabau J; Arzamendi D
    JAMA Cardiol; 2024 Oct; 9(10):922-926. PubMed ID: 39110427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin K antagonists with or without long-term antiplatelet therapy in outpatients with stable coronary artery disease and atrial fibrillation: Association with ischemic and bleeding events.
    Lemesle G; Ducrocq G; Elbez Y; Van Belle E; Goto S; Cannon CP; Bauters C; Bhatt DL; Steg PG;
    Clin Cardiol; 2017 Oct; 40(10):932-939. PubMed ID: 28692742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.